Thursday’s Top Stocks Upgrades (KEY, ENS, DLB, ALXN)

KeyCorp (NYSE:KEY) surged 0.85% to $8.31 in the opening session following Credit Suisse upgraded the company’s shares to Outperform from Neutral, earlier.

Over the past 52-week, the stock has been made high and low of $9.84 and $4.40 respectively. So far this year, the stock is up about 47% and outperformed the broader market.

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

EnerSys (NYSE:ENS) was also upgraded by Ardour Capital today morning to Buy from Accumulate with a price target of $30. Over the past 52-week, the stock has been made high and low of $27.23 and $15.91 respectively. So far this year, the stock is up about 9.50%.

EnerSys is a manufacturer, marketer and distributor of industrial batteries. The Company also manufactures markets and distributes related products, such as chargers, power equipment and battery accessories, and it provides related after-market and customer-support services for industrial batteries.

Dolby Laboratories, Inc. (NYSE:DLB) shares climbed 2.62% to $67.87 as today analyst at JPMorgan upgraded the company’s stock to Overweight. Over the past 52-week, the stock has been made high and low of $69.72 and $34.14 respectively. So far this year, the stock is up about 42.30%.

Dolby Laboratories, Inc. develops and delivers products and technologies that are used in the entertainment industry. The Company’s technologies are used in digital versatile disc (DVD), players and personal computer DVD playback software, digital televisions, set top boxes, portable media devices and in a range of consumer electronic products, such as gaming systems and audio/video receivers.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) also climbed by 2% to $53.37 after Oppenheimer analyst upped their rating on the company’s share  to Outperform from Market Perform, while maintained the price target of $62.

Over the past 52-week, the stock has been made high and low of $57.20 and $36.36 respectively. So far this year, the stock is up about 10%.

Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.